Anand U, Yiangou Y, Akbar A, Quick T, MacQuillan A, Fox M, Sinisi M, Korchev YE, Jones B, Bloom SR, Anand P (2018) Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons
The high cost of GLP-1 analogue therapies, coupled with significant reimbursement challenges, presents a key obstacle to broader market penetration and patient access
Semaglutide pharmacokinetic profiles covering a 1-week dosing interval after a single dose and simulated at steady state are presented in Fig
Weeks 1 through 4: the initiation phase (0.25 mg) This is not a therapeutic dose for weight loss